Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles

Background: Development of new drug carriers would be an interesting approach if it allowed increased efficacy of antibiotics and a reduction in doses, thus reducing the risk of developing resistance. As with most drug carriers, niosomes have been used to improve the selective delivery and the therapeutic index of antimicrobial agents. Methods: In this study, different formulation of niosomes containing ciprofloxacin (CPFX), Span (20, 60 or 80), Tween (20, 60 or 80) and cholesterol were prepared by film hydration method. The release of the drug from different formulations was studied by using Franz diffusion cell. The niosomes were further characterized by optical microscopy and particle size analysis, and their antimicrobial activity was evaluated. Results: Size of the niosomes was significantly dependent on the amount of cholesterol and surfactant type and varied from 8.56 to 61.3 μm. The entrapment efficiency of CPFX niosomes prepared by remote loading was more than 74%. Niosomes composed of Span/Tween 60 provided a higher CPFX release rate than other formulations. The obtained results indicated a diffusion-based mechanism for drug leakage through bilayers. All formulations presented more antibacterial activity as compared to free CPFX solution. Conclusion: Niosomal CPFX appears to be a promising approach in the management of bacterial infections, especially ophthalmic ones, and should be further evaluated by in vivo experiments.

[1]  Nikhil Biswas,et al.  Nonionic Surfactant Vesicles in Ocular Delivery: Innovative Approaches and Perspectives , 2014, BioMed research international.

[2]  H. Abdelkader,et al.  Effects of surfactant type and cholesterol level on niosomes physical properties and in vivo ocular performance using timolol maleate as a model drug , 2014, Journal of Pharmaceutical Investigation.

[3]  A. Pardakhty,et al.  Nano-niosomes in drug, vaccine and gene delivery: a rapid overview , 2013 .

[4]  Azza A. Hasan,et al.  Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system , 2013, Drug delivery.

[5]  A. Pardakhty,et al.  Ciprofloxacin nano-niosomes for targeting intracellular infections: an in vitro evaluation , 2013, Journal of nanoparticle research.

[6]  S. Chaudhari,et al.  Niosomes: novel sustained release nonionic stable vesicular systems--an overview. , 2012, Advances in colloid and interface science.

[7]  S. Moghim,et al.  Comparison of Epothilone and Taxol Binding in Yeast Tubulin using Molecular Modeling , 2011, Avicenna journal of medical biotechnology.

[8]  R. Alany,et al.  Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. , 2011, Journal of pharmaceutical sciences.

[9]  Z. Drulis-Kawa,et al.  Liposomes as delivery systems for antibiotics. , 2010, International journal of pharmaceutics.

[10]  O. Sammour,et al.  Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. , 2008, International journal of pharmaceutics.

[11]  J. Gubernator,et al.  IN VITRO ANTIMICROBIAL ACTIVITY OF LIPOSOMES CONTAINING CIPROFLOXACIN, MEROPENEM AND GENTAMICIN AGAINST GRAM-NEGATIVE CLINICAL BACTERIAL STRAINS , 2007 .

[12]  A. Pardakhty,et al.  In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. , 2007, International journal of pharmaceutics.

[13]  A. Pardakhty,et al.  Caffeine-Loaded Niosomes: Characterization and in Vitro Release Studies , 2007, Drug delivery.

[14]  Rania M. Hathout,et al.  Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. , 2005, International journal of pharmaceutics.

[15]  Richard A. Durst,et al.  Liposome encapsulation of fluorescent nanoparticles: Quantum dots and silica nanoparticles , 2005 .

[16]  J. Knuuti,et al.  Efficacy of Ciprofloxacin-Releasing Bioabsorbable Osteoconductive Bone Defect Filler for Treatment of Experimental Osteomyelitis Due to Staphylococcus aureus , 2005, Antimicrobial Agents and Chemotherapy.

[17]  J. Hernández-Borrell,et al.  Does ciprofloxacin interact with neutral bilayers? An aspect related to its antimicrobial activity. , 2003, International journal of pharmaceutics.

[18]  A. Pardakhty,et al.  Development and Physical Characterization of Sorbitan Monoester Niosomes for Insulin Oral Delivery , 2003, Drug delivery.

[19]  K. Li,et al.  Studies on a high encapsulation of colchicine by a niosome system. , 2002, International journal of pharmaceutics.

[20]  C. Oliphant,et al.  Quinolones: a comprehensive review. , 2002, American family physician.

[21]  O. Lorenzetti,et al.  Ocular bioavailability of ciprofloxacin in sustained release formulations. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[22]  L. Peltonen The Interfacial Behaviour of Sorbitan Surfactant Monolayers and the Bulk Properties of These Surfactants as a Function of Temperature , 2001 .

[23]  J. Hadgraft,et al.  Topical delivery of caffeine from some commercial formulations. , 1999, International journal of pharmaceutics.

[24]  F. Bonini,et al.  Ciprofloxacin-loaded polyisobutylcyanoacrylate nanoparticles: pharmacokinetics and in vitro antimicrobial activity , 1998 .

[25]  Y. Oh,et al.  Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection , 1995, Antimicrobial agents and chemotherapy.

[26]  A. Florence,et al.  Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85) , 1994 .

[27]  A. Mitra,et al.  Pharmacodynamics of Insulin Following Intravenous and Enteral Administrations of Porcine-Zinc Insulin to Rats , 1992, Pharmaceutical Research.

[28]  J. Gier,et al.  Lipid composition and permeability of liposomes. , 1968, Biochimica et biophysica acta.

[29]  S. Kumar,et al.  VESICULAR SYSTEMCARRIER FOR DRUG DELIVERY , 2011 .

[30]  A. Jha,et al.  Vesicular System-Carrier for Drug Delivery , 2011 .

[31]  P. Luo,et al.  Synthesis and characterization of hydroxyapatite-ciprofloxacin delivery systems by precipitation and spray drying technique , 2008, AAPS PharmSciTech.

[32]  C. Cable An examination of the effect of surface modifications on the physicochemical and biological properties of non-ionic surfactant vesicles , 1990 .

[33]  D. Maurice,et al.  The influence of non-ionic detergents and other surfactants on human corneal permeability. , 1971, Experimental eye research.